ask="N/A"
ask_size="N/A"
average_daily_volume="219859"
bid="28.56"
bid_size="1000"
book_value="3.79"
change="-0.02"
change_from_200_day_moving_average="2.65"
change_from_50_day_moving_average="0.19"
change_from_52_week_high="-4.27"
change_From_52_week_low="14.86"
change_in_percent="-0.07%"
close="28.98"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-3.04"
eps_estimate_next_quarter="-0.70"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="15981000"
high="30.06"
high_52_weeks="33.25"
last_trade_date="3/17/2017"
last_trade_price="28.98"
last_trade_size="42369"
last_trade_time="4:00pm"
low="28.81"
low_52_weeks="14.12"
market_capitalization="621.10M"
moving_average_200_day="26.33"
moving_average_50_day="28.79"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="41.00"
open="29.00"
pe_ratio="N/A"
peg_ratio="-0.13"
percent_change_from_200_day_moving_average="+10.06%"
percent_change_from_50_day_moving_average="+0.64%"
percent_change_from_52_week_high="-12.84%"
percent_change_from_52_week_low="+105.24%"
previous_close="29.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.66"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.77"
stock_exchange="NMS"
symbol="ACRS"
volume="210597"
weeks_range_52="14.12 - 33.25"
